Biotech Firm Plans Virtual Investor Meetings for Hong Kong IPO - (Bloomberg via NewsPoints Desk)

  • InnoCare Pharma, which canceled investor meetings for its Hong Kong initial public offering earlier this month due to the COVID-19 outbreak, is planning to hold them as soon as next week, but likely virtually, reported Bloomberg.

  • The Chinese biotechnology firm aims to raise about $200 million to $300 million in the first-time share sale, said people familiar with the matter.

  • InnoCare is considering holding most of the meetings with prospective investors via video or phone calls, according to the people.

To read more NewsPoints articles, click here.